STOKE THERAPEUTICS INC's ticker is STOK and the CUSIP is 86150R107. A total of 72 filers reported holding STOKE THERAPEUTICS INC in Q2 2020. The put-call ratio across all filers is - and the average weighting 1.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $2,329,283 | -63.5% | 591,117 | -1.4% | 0.00% | -100.0% |
Q2 2023 | $6,375,661 | +57.3% | 599,780 | +23.2% | 0.00% | 0.0% |
Q1 2023 | $4,054,044 | +92521.5% | 486,680 | +2.6% | 0.00% | 0.0% |
Q4 2022 | $4,377 | -99.9% | 474,224 | +3.0% | 0.00% | 0.0% |
Q3 2022 | $5,909,000 | +0.8% | 460,255 | +3.7% | 0.00% | 0.0% |
Q2 2022 | $5,862,000 | -36.1% | 443,809 | +1.8% | 0.00% | 0.0% |
Q1 2022 | $9,172,000 | +1.7% | 435,771 | +15.8% | 0.00% | 0.0% |
Q4 2021 | $9,023,000 | -2.4% | 376,154 | +3.5% | 0.00% | 0.0% |
Q3 2021 | $9,243,000 | -22.9% | 363,335 | +2.0% | 0.00% | -50.0% |
Q2 2021 | $11,991,000 | +5.4% | 356,246 | +21.6% | 0.00% | 0.0% |
Q1 2021 | $11,381,000 | -32.2% | 293,036 | +8.1% | 0.00% | -33.3% |
Q4 2020 | $16,793,000 | +148.0% | 271,165 | +34.1% | 0.00% | +200.0% |
Q3 2020 | $6,771,000 | +77.7% | 202,189 | +26.4% | 0.00% | 0.0% |
Q2 2020 | $3,811,000 | -10.5% | 159,944 | -13.9% | 0.00% | 0.0% |
Q1 2020 | $4,256,000 | -37.2% | 185,856 | -22.4% | 0.00% | 0.0% |
Q4 2019 | $6,780,000 | +179.8% | 239,434 | +112.4% | 0.00% | 0.0% |
Q3 2019 | $2,423,000 | – | 112,752 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Octagon Capital Advisors LP | 296,822 | $7,551,000 | 1.86% |
RTW INVESTMENTS, LP | 3,644,248 | $92,710,000 | 1.40% |
Cormorant Asset Management, LP | 1,278,276 | $32,519,000 | 1.32% |
Redmile Group, LLC | 2,381,958 | $60,597,000 | 1.06% |
HighVista Strategies LLC | 47,594 | $1,211,000 | 0.80% |
Birchview Capital, LP | 15,000 | $382,000 | 0.26% |
GILDER GAGNON HOWE & CO LLC | 1,123,355 | $28,578,000 | 0.15% |
Artal Group S.A. | 250,000 | $6,360,000 | 0.14% |
Tekla Capital Management LLC | 99,263 | $2,525,000 | 0.08% |
Casdin Capital, LLC | 120,000 | $3,053,000 | 0.08% |